184 related articles for article (PubMed ID: 30867672)
1. Comparative efficacy of steroid-sparing therapies for non-infectious uveitis.
Knickelbein JE; Kim M; Argon E; Nussenblatt RB; Sen NH
Expert Rev Ophthalmol; 2017; 12(4):313-319. PubMed ID: 30867672
[TBL] [Abstract][Full Text] [Related]
2. The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis.
Waszczyk-Łączak M; Łazicka-Gałecka M; Chomicz L; Mucha K; Pączek L; Szaflik JP
Ann Agric Environ Med; 2020 Dec; 27(4):644-649. PubMed ID: 33356073
[TBL] [Abstract][Full Text] [Related]
3. Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease.
Baker KB; Spurrier NJ; Watkins AS; Smith JR; Rosenbaum JT
Br J Ophthalmol; 2006 Dec; 90(12):1481-5. PubMed ID: 16914474
[TBL] [Abstract][Full Text] [Related]
4. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR;
JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for uveitis.
Larson T; Nussenblatt RB; Sen HN
Expert Opin Emerg Drugs; 2011 Jun; 16(2):309-22. PubMed ID: 21210752
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive therapy in severe or chronic pediatric uveitis: Review of the literature].
Stolowy N; Zanin E; Comet A; Jurquet AL; Benso C; Matonti F; Retornaz K; Kaplanski G; Denis D
J Fr Ophtalmol; 2021 Feb; 44(2):252-258. PubMed ID: 33423814
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
Rathinam SR; Babu M; Thundikandy R; Kanakath A; Nardone N; Esterberg E; Lee SM; Enanoria WT; Porco TC; Browne EN; Weinrib R; Acharya NR
Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.
Miraldi Utz V; Bulas S; Lopper S; Fenchel M; Sa T; Mehta M; Ash D; Lovell DJ; Kaufman AH
Pediatr Rheumatol Online J; 2019 Nov; 17(1):79. PubMed ID: 31783768
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic non-infectious uveitis and scleritis.
Rossi DC; Ribi C; Guex-Crosier Y
Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression.
Becker MD; Wertheim MS; Smith JR; Rosenbaum JT
Ocul Immunol Inflamm; 2005; 13(4):289-93. PubMed ID: 16159719
[TBL] [Abstract][Full Text] [Related]
11. An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.
Sood AB; Angeles-Han ST
Curr Treatm Opt Rheumatol; 2017 Mar; 3(1):1-16. PubMed ID: 28944162
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
Nguyen QD; Merrill PT; Jaffe GJ; Dick AD; Kurup SK; Sheppard J; Schlaen A; Pavesio C; Cimino L; Van Calster J; Camez AA; Kwatra NV; Song AP; Kron M; Tari S; Brézin AP
Lancet; 2016 Sep; 388(10050):1183-92. PubMed ID: 27542302
[TBL] [Abstract][Full Text] [Related]
13. Overview and recent developments in the medical management of paediatric uveitis.
Pilly B; Heath G; Tschuor P; Lightman S; Gale RP
Expert Opin Pharmacother; 2013 Sep; 14(13):1787-95. PubMed ID: 23826652
[TBL] [Abstract][Full Text] [Related]
14. Expert opinion on the use of biological therapy in non-infectious uveitis.
Touhami S; Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
Expert Opin Biol Ther; 2019 May; 19(5):477-490. PubMed ID: 30888881
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis.
Browne EN; Rathinam SR; Kanakath A; Thundikandy R; Babu M; Lietman TM; Acharya NR
Ophthalmic Epidemiol; 2017 Feb; 24(1):63-70. PubMed ID: 27982726
[TBL] [Abstract][Full Text] [Related]
16. Earlier use of systemic immunosuppression is associated with fewer ophthalmic surgeries in paediatric non-infectious uveitis.
Cheung CSY; Mireskandari K; Ali A; Silverman E; Tehrani N
Br J Ophthalmol; 2020 Jul; 104(7):938-942. PubMed ID: 31604701
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.
Kiss S; Ahmed M; Letko E; Foster CS
Ophthalmology; 2005 Jun; 112(6):1066-71. PubMed ID: 15936442
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Oray M; Tuğal-Tutkun İ
Turk J Ophthalmol; 2016 Apr; 46(2):77-82. PubMed ID: 27800265
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.
Fabiani C; Vitale A; Rigante D; Emmi G; Bitossi A; Lopalco G; Sota J; Guerriero S; Orlando I; Gentileschi S; Iannone F; Frediani B; Galeazzi M; Vannozzi L; Tosi GM; Cantarini L
Clin Rheumatol; 2019 Feb; 38(2):407-415. PubMed ID: 30099655
[TBL] [Abstract][Full Text] [Related]
20. Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.
Massa H; Pipis SY; Adewoyin T; Vergados A; Patra S; Panos GD
Clin Ophthalmol; 2019; 13():1761-1777. PubMed ID: 31571815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
